Table 2 Characteristics of anti-malarial customers
Pre-intervention | Post-intervention | |||||||
|---|---|---|---|---|---|---|---|---|
Subsidized (n = 91) | Unsubsidized (n = 82) | Control (n = 86) | χ 2 p value | Subsidized (n = 266) | Unsubsidized (n = 330) | Control (n = 359) | χ 2 p value | |
Customer age (median, range) | 30 (18–67) | 34 (18–68) | 33 (18–83) | 30 (6–79) | 32 (12–92) | 30 (14–82) | ||
Male (%, 95% CI) | 44.0 (33.7–54.3) | 47.6 (36.6–58.5) | 52.3 (41.7–63.0) | 0.536 | 47.4 (41.3–53.4) | 49.4 (44.0–54.8) | 51.5 (46.3–56.7) | 0.585 |
Completed > Primary school (%, 95% CI) | 15.4 (7.9–22.9) | 24.4 (15.0–33.8) | 20.9 (12.2–29.6) | 0.327 | 21.1 (16.1–26.0) | 13.9 (10.2–17.7) | 21.2 (16.9–25.4) | 0.025 |
Wealth quintile (%, 95% CI) | ||||||||
Lowest | 14.3 (7.0–21.5) | 30.5 (20.4–40.6) | 17.4 (9.3–25.5) | 0.337 | 17.7 (13.1–22.3) | 18.2 (14.1–22.4) | 24.8 (20.3–29.3) | 0.248 |
Lower | 20.9 (12.4–29.3) | 18.3 (9.8–26.8) | 20.9 (12.2–29.6) | 21.8 (16.8–26.8) | 21.9 (17.4–26.4) | 18.1 (14.1–22.1) | ||
Middle | 23.1 (14.3–31.8) | 13.4 (6.0–20.9) | 22.1 (13.2–31.0) | 22.9 (17.9–28.0) | 18.2 (14.1–22.4) | 20.6 (16.4–24.8) | ||
Higher | 20.9 (12.4–29.3) | 20.7 (11.9–29.6) | 20.9 (12.2–29.6) | 20.3 (15.5–25.1) | 21.3 (16.8–25.7) | 17.5 (13.6–21.5) | ||
Highest | 20.9 (12.4–29.3) | 17.1 (8.8–25.3) | 18.6 (10.3–26.9) | 17.3 (12.7–21.9) | 20.4 (16.0–24.7) | 18.9 (14.9–23.0) | ||
Patient is customer or is with customer (present at ADDO) (%, 95% CI) | 59.3 (49.1–69.5) | 59.1 (45.2–67.0) | 68.6 (58.7–78.5) | 0.221 | 81.6 (76.9–86.3) | 74.8 (70.2–79.5) | 68.0 (63.1–72.8) | 0.001 |